Enlyte reported that spending on specialty drugs, such as HIV and cancer medications, has nearly tripled during the past six years. Although they make up for less than 2% of total prescription volume, specialty drugs now account for more than 15% of total spending. Credit: wollertz/Adobe Stock Enlyte reported that spending on specialty drugs, such as HIV and cancer medications, has nearly tripled during the past six years. Although they make up for less than 2% of total prescription volume, specialty drugs now account for more than 15% of total spending. Credit: wollertz/Adobe Stock

In 2023, opioid utilization in workers' compensation claims saw one of its largest declines in recent years, according to Enlyte Group, LLC. Utilization declined 9.7% per claim and cost decreased 7.2% per claim.

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

  • All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Steve Hallo

Steve Hallo is managing editor of PropertyCasualty360.com. He can be reached at [email protected]

Education & Training
Workers' Comp